150 related articles for article (PubMed ID: 10619497)
1. Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group.
Gregor A; Lind M; Newman H; Grant R; Hadley DM; Barton T; Osborn C
J Neurooncol; 1999 Sep; 44(2):137-45. PubMed ID: 10619497
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma.
Ford J; Osborn C; Barton T; Bleehen NM
Eur J Cancer; 1998 Oct; 34(11):1807-11. PubMed ID: 9893673
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas.
Cloughesy TF; Black KL; Gobin YP; Farahani K; Nelson G; Villablanca P; Kabbinavar F; Viñeula F; Wortel CH
Neurosurgery; 1999 Feb; 44(2):270-8; discussion 278-9. PubMed ID: 9932880
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
Prados MD; Schold SC; Fine HA; Jaeckle K; Hochberg F; Mechtler L; Fetell MR; Phuphanich S; Feun L; Janus TJ; Ford K; Graney W
Neuro Oncol; 2003 Apr; 5(2):96-103. PubMed ID: 12672281
[TBL] [Abstract][Full Text] [Related]
5. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology Group.
Warren K; Jakacki R; Widemann B; Aikin A; Libucha M; Packer R; Vezina G; Reaman G; Shaw D; Krailo M; Osborne C; Cehelsky J; Caldwell D; Stanwood J; Steinberg SM; Balis FM
Cancer Chemother Pharmacol; 2006 Sep; 58(3):343-7. PubMed ID: 16408203
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Black KL; Cloughesy T; Huang SC; Gobin YP; Zhou Y; Grous J; Nelson G; Farahani K; Hoh CK; Phelps M
J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.
Robins HI; Chang SM; Prados MD; Yung WK; Hess K; Schiff D; Greenberg H; Fink K; Nicolas K; Kuhn JG; Cloughesy T; Junck L; Mehta M
Neuro Oncol; 2002 Apr; 4(2):109-14. PubMed ID: 11916502
[TBL] [Abstract][Full Text] [Related]
10. Imaging response to chemotherapy with RMP-7 and carboplatin in malignant glioma: size matters but speed does not.
Grant R; Walker M; Hadley D; Barton T; Osborn C
J Neurooncol; 2002 May; 57(3):241-5. PubMed ID: 12125987
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Sep; 104(6):1281-7. PubMed ID: 16078267
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours.
Thomas HD; Lind MJ; Ford J; Bleehen N; Calvert AH; Boddy AV
Cancer Chemother Pharmacol; 2000; 45(4):284-90. PubMed ID: 10755316
[TBL] [Abstract][Full Text] [Related]
13. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.
Qureshi AI; Suri MF; Khan J; Sharma M; Olson K; Guterman LR; Hopkins LN
J Neurooncol; 2001 Jan; 51(2):151-8. PubMed ID: 11386412
[TBL] [Abstract][Full Text] [Related]
14. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
Emerich DF; Snodgrass P; Dean R; Agostino M; Hasler B; Pink M; Xiong H; Kim BS; Bartus RT
Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
[TBL] [Abstract][Full Text] [Related]
16. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.
Roci E; Cakani B; Brace G; Bushati T; Rroji A; Petrela M; Kaloshi G
Med Arch; 2014; 68(2):140-3. PubMed ID: 24937942
[TBL] [Abstract][Full Text] [Related]
18. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
[TBL] [Abstract][Full Text] [Related]
19. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
20. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]